APYDAN extent cpr 150 mg bte 50 pce
7680578830020
CH-57883
N03AF02
01.07.1.
1 / 3
google
Details
- Product number
- 5788301
- CPT
- -
- Packaging group
- 50
- Unit
- Tablette(n)
- Composition
- oxcarbazepinum 150 mg, ammonio methacrylatis copolymerum B, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.08 mg, magnesii stearas, E 101 pro compresso.
Articles (1)
Apydan extent 150 mg, Tabletten
Tabletten
50
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.08 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 16.85
Specialties list
Yes
Generic
No
SL addition date:
01/05/2011
Authorization holder
Desitin Pharma GmbH
4410 Liestal
Authorization information
- Swissmedic authorization number
- 57883
- Drug name
- Apydan extent, Tabletten
- Galenic form
- TABWF
- ATC Code
- N03AF02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/11/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 01.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- APYDAN extent cpr 150 mg bte 50 pce
- Description (DE)
- APYDAN extent Tabl 150 mg Ds 50 Stk
- Market launch
- 10/11/2010
- Narcotic (BTM)
- No